Turn your signature into dozens more by sharing this petition and recruiting people you know to sign.
The National Institute for Health and Care Excellence (England/Wales) and the Scottish Medicines Consortium have both rejected the breast cancer treatment Afinitor for use by the NHS on the grounds that it is not "cost effective". Metastatic breast cancer (i.e. breast cancer which has spread to other parts of the body) has limited treatment options and is killing thousands of women every year in the UK. Brilliant research is being done into producing targeted drugs such as Afinitor for this form of the disease, but this will be in vain if patients cannot get access to them. People's lives should not be shortened because NICE and the SMC have decided that such a drug is not a good use of NHS money.
Whom it may concern, NICE
Whom it may concern, SMC
Please reverse your decision to reject the breast cancer treatment Afinitor for use by the NHS on the grounds that it is not cost-effective.
Please check your inbox. We need to confirm that you're you.
Your signature resembles the name of a public figure. We just sent you a confirmation email to keep your identity safe. After we verify your email address, we'll post the signature. Thanks!